Sunitinib G.L. Pharma

Sunitinib G.L. Pharma is an oral medication used for treating certain types of cancer. It belongs to a class of drugs known as tyrosine kinase inhibitors. This product is manufactured by G.L. Pharma GmbH and is available in the EU. sunitinib capsules for cancer treatment sunitinib g.l. pharma 12.5 mg

Sunitinib is prescribed to manage gastrointestinal stromal tumors, advanced renal cell carcinoma, and pancreatic neuroendocrine tumors. It works by slowing or stopping the growth of cancer cells. Patients often ask, what is sunitinib used for, as it targets specific pathways in tumor progression. This medication is taken by mouth and is suitable for adults under medical supervision.

Common effects of sunitinib include fatigue, nausea, and digestive discomfort. Some users may experience changes in skin color or hair thinning. These effects are generally temporary and vary by individual. It is important to monitor how the body responds during treatment.

Store sunitinib at room temperature away from moisture and heat. Keep the medication in its original packaging to protect it from light. Always handle with care and follow local disposal guidelines for unused or expired drugs. Avoid crushing or splitting capsules unless directed by a healthcare provider.

Sunitinib may interact with other medications, including certain antidepressants, antibiotics, and blood thinners. Grapefruit and grapefruit juice can affect how the body processes sunitinib. It is advisable to discuss all current medications with a healthcare professional before starting treatment.